Impel NeuroPharma’s $80 Million Initial Public Offering

Fenwick & West LLP advised Impel NeuroPharma on the deal.Impel NeuroPharma, a late-stage pharmaceutical company developing transformative therapies for diseases of the central nervous system, announced its initial…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now